Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG

Immunity and Ageing

Volumn 10, Issue 1, 2013, Pages

  Taniguchi, Keiichi ^a   Takii, Takemasa ^a   Yamamoto, Saburo ^b   Maeyama, Jun ichi ^c   Iho, Sumiko ^d   Maruyama, Mitsuo ^e   Iizuka, Narushi ^f   Ozeki, Yuriko ^g,h   Matsumoto, Sohkichi ^h   Hasegawa, Tomohiro ^a   Miyatake, Yuuji ^a   Itoh, Saotomo ^a   Onozaki, Kikuo ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b Kiyose   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

^e NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g Sonoda Women's University   (Japan)

^h OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; BCG; Booster; CpG oligomer; Mycobacterium tuberculosis

Indexed keywords

BCG VACCINE; CD44V ANTIGEN; CPG OLIGOMER; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; L SELECTIN; MYCOBACTERIUM ANTIGEN; OLIGOMER; TUBERCULIN; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL IMMUNITY; BCG VACCINATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; INTERFERON PRODUCTION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TUBERCULOSIS;

EID: 84879110589     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-10-25     Document Type: Article

References (25)

1. WHO BCG (Tuberculosis) 2011, http://www.who.int/biologicals/areas/vaccines/bcg/Tuberculosis/en/, WHO.
2. Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977, 2:293-295. 10.1136/bmj.2.6082.293, 1630784, 326347.
3. WHO BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bull World Health Organ 1972, 46:371-385. 2480749, 4537855, WHO.
4. Brooks JV, Frank AA, Keen MA, Bellisle JT, Orme IM. Boosting vaccine for tuberculosis. Infect Immun 2001, 69:2714-2717. 10.1128/IAI.69.4.2714-2717.2001, 98211, 11254639.
5. Brennan MJ, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo AA, Barker LF. Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine 2012, 30:2811-2823. 10.1016/j.vaccine.2012.02.036, 3335191, 22387630.
6. Broux B, Markovic-Plese S, Stinissen P, Hellings N. Pathogenic features of CD4(+)CD28(-) T cells in immune disorders. Trends Mol Med 2012, 18:446-453. 10.1016/j.molmed.2012.06.003, 22784556.
7. Haynes L, Lefebvre JS. Age-related Deficiencies in Antigen-Specific CD4 T cell Responses: Lessons from Mouse Models. Aging Dis 2011, 2:374-381. 3295078, 22396889.
8. Lee N, Shin MS, Kang I. T-cell biology in aging, with a focus on lung disease. J Gerontol A Biol Sci Med Sci 2012, 67:254-263. 3297764, 22396471.
9. Ito T, Takii T, Maruyama M, Hayashi D, Wako T, Asai A, Horita Y, Taniguchi K, Yano I, Yamamoto S, Onozaki K. Effectiveness of BCG vaccination to aged mice. Immun Ageing 2010, 7:12. 10.1186/1742-4933-7-12, 2936867, 20809944.
10. Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM. Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol 2010, 17:618-625. 10.1128/CVI.00368-09, 2849327, 20107011.
11. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009, 182:8047-8055. 10.4049/jimmunol.0801592, 19494330.
12. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992, 36:983-997.
13. Maeyama J, Komiya T, Takahashi M, Isaka M, Goto N, Yamamoto S. The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid. Vaccine 2009, 27:1166-1173. 10.1016/j.vaccine.2008.12.025, 19136040.
14. Ozeki Y, Hirayama Y, Takii T, Yamamoto S, Kobayashi K, Matsumoto S. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guerin. Vaccine 2011, 29:6881-6887. 10.1016/j.vaccine.2011.07.051, 21803102.
15. Kim YT, Goidl EA, Samarut C, Weksler ME, Thorbecke GJ, Siskind GW. Bone marrow function I. Peripheral T cells are responsible for the increased auto-antiidiotype response of older mice. J Exp Med 1985, 161:1237-1242. 10.1084/jem.161.5.1237, 2187606, 3886829.
16. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003, 23:15-39. 10.1016/S0889-8561(02)00056-5, 12645876.
17. Freidag BL, Melton GB, Collins F, Klinman DM, Cheever A, Stobie L, Suen W, Seder RA. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun 2000, 68:2948-2953. 10.1128/IAI.68.5.2948-2953.2000, 97508, 10768993.
18. Ballester M, Nembrini C, Dhar N, De Titta A, De Piano C, Pasquier M, Simeoni E, van der Vlies AJ, McKinney JD, Hubbell JA, Swartz MA. Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis. Vaccine 2011, 29:6959-6966. 10.1016/j.vaccine.2011.07.039, 21787826.
19. Silva BD, Da Silva EB, Do Nascimento IP, Dos Reis MC, Kipnis A, Junqueira-Kipnis AP. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis. Vaccine 2009, 27:4402-4407. 10.1016/j.vaccine.2009.05.049, 19500525.
20. Da Fonseca DM, Silva CL, Wowk PF, Paula MO, Ramos SG, Horn C, Marchal G, Bonato VL. Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion. Infect Immun 2009, 77:5311-5321. 10.1128/IAI.00580-09, 2786481, 19752029.
21. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20:709-760. 10.1146/annurev.immunol.20.100301.064842, 11861616.
22. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Sandor M, Lukacs NW, Chensue SW, Kunkel SL. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 2009, 119:33-46. 2613456, 19075396.
23. Khader SA, Cooper AM. IL-23 and IL-17 in tuberculosis. Cytokine 2008, 41:79-83. 10.1016/j.cyto.2007.11.022, 2266085, 18218322.
24. Ancelet L, Rich FJ, Delahunt B, Kirman JR. Dissecting memory T cell responses to TB: Concerns using adoptive transfer into immunodeficient mice. Tuberculosis (Edinb) 2012, 92:422-433.
25. Nambiar JK, Pinto R, Aguilo JI, Takatsu K, Martin C, Britton WJ, Triccas JA. Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory. Eur J Immunol 2012, 42:385-392. 10.1002/eji.201141903, 22105536.